3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
11
Breast Neoplasms
10
Ovarian Neoplasms
9
Triple Negative Breast Neoplasms
8
Endometrial Neoplasms
8
Uterine Cervical Neoplasms
5
Esophageal Neoplasms
5
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Fallopian Tube Neoplasms
4
Pancreatic Neoplasms
3
Neoplasms
3
Small Cell Lung Carcinoma
2
Recurrence
2
NSCLC
2
Mouth Neoplasms
2
Laryngeal Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Ovarian Epithelial
2
Unresectable Locally Advanced or Metastatic Solid Tumors
1
Thyroid Neoplasms
1
Stage III and IV Ovarian Cancer
1
Squamous Non-small Cell Lung Cancer
1
Solid Tumor Cancer
1
Sarcoma, Kaposi
1
Respiratory Tract Neoplasms
1
Platinum-sensitive Relapsed Ovarian Cancer
1
Platinum-Resistant Primary Peritoneal Carcinoma
1
Pancreatic Intraductal Neoplasms
1
PDAC - Pancreatic Ductal Adenocarcinoma
1
Interventions
senaparib
1
sargramostim
1
niraparib
1
Saline Solution
1
Paclitaxel
1
Carboplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Advanced Ovarian Cancer
×
Paclitaxel
×
Clear all
NCT05794659
2023-07-20
Cornerstone4
Aston Sci. Inc.
Phase 2
Not yet recruiting
98 enrolled